Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-23 18:26:17 UTC |
---|
Update Date | 2014-12-24 20:25:59 UTC |
---|
Accession Number | T3D3102 |
---|
Identification |
---|
Common Name | Bromadiolone |
---|
Class | Small Molecule |
---|
Description | Bromadiolone is a potent anticoagulant and rodenticide. It is a second-generation coumarin derivative, often called a "super-warfarin" for its added potency and tendency to accumulate in the liver of the poisoned organism. (3) |
---|
Compound Type | - Aromatic Hydrocarbon
- Bromide Compound
- Ester
- Organic Compound
- Organobromide
- Pesticide
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | Boldo | Boot hill | Bromadiolon | Bromatrol | Bromodialone | Bromodiolone | Bromone | Bromore | Broprodifacoum | Canadien 2000 | Contrac | Contrax | Eradic | MAKI | Rafix | Ratimus | Rotox | Sup'operats | Super-caid | Super-cald | Super-rozol | Temus | Topidion |
|
---|
Chemical Formula | C30H23BrO4 |
---|
Average Molecular Mass | 527.405 g/mol |
---|
Monoisotopic Mass | 526.078 g/mol |
---|
CAS Registry Number | 28772-56-7 |
---|
IUPAC Name | 3-{3-[4-(4-bromophenyl)phenyl]-3-hydroxy-1-phenylpropyl}-2-hydroxy-4H-chromen-4-one |
---|
Traditional Name | bromadiolone |
---|
SMILES | OC(CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O)C1=CC=C(C=C1)C1=CC=C(Br)C=C1 |
---|
InChI Identifier | InChI=1S/C30H23BrO4/c31-23-16-14-20(15-17-23)19-10-12-22(13-11-19)26(32)18-25(21-6-2-1-3-7-21)28-29(33)24-8-4-5-9-27(24)35-30(28)34/h1-17,25-26,32,34H,18H2 |
---|
InChI Key | InChIKey=IUZFQERQUZLNKQ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as linear diarylheptanoids. These are diarylheptanoids with an open heptane chain. The two aromatic rings are linked only by the heptane chain. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Diarylheptanoids |
---|
Sub Class | Linear diarylheptanoids |
---|
Direct Parent | Linear diarylheptanoids |
---|
Alternative Parents | |
---|
Substituents | - Linear 1,7-diphenylheptane skeleton
- Homoisoflavone
- Linear 1,3-diarylpropanoid
- Brominated biphenyl
- Biphenyl
- Chromone
- Coumarin
- 1-benzopyran
- Benzopyran
- Pyranone
- Bromobenzene
- Halobenzene
- Aryl bromide
- Benzenoid
- Aryl halide
- Monocyclic benzene moiety
- Pyran
- Heteroaromatic compound
- Vinylogous acid
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Organic oxide
- Organohalogen compound
- Organobromide
- Alcohol
- Organooxygen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 205°C | Boiling Point | Not Available | Solubility | 0.019 mg/mL at 20°C [TOMLIN,C (1997)] | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a6r-0011090000-fa4ac84af89c0835fbd5 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-08fr-0092250000-51693136ff8e8fa0dc2f | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0ir0-0391100000-9416a9a0d039c5a29b84 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0010970000-0f6977de39ba6a7975d6 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03gi-0340950000-e863bcdfd1f358552f31 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-001i-3290500000-1aecac71621da29b0b06 | 2016-08-03 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral (ingestion) (4) ; dermal (4) |
---|
Mechanism of Toxicity | Bromadiolone inhibits the enzyme Vitamin K epoxide reductase. This enzyme is needed for the reconstitution of the vitamin K in its cycle from vitamin K-epoxide, and so bromadiolone steadily decreases the level of active vitamin K in the blood. Vitamin K is required for the synthesis of important substances including prothrombin, which is involved in blood clotting. This disruption becomes increasingly severe until the blood effectively loses any ability to clot. In addition, bromadiolone increases permeability of blood capillaries. The blood plasma and blood itself begins to leak from the blood vessels, causing internal bleeding leading to shock, loss of consciousness, and eventually death. (2) |
---|
Metabolism | Not Available |
---|
Toxicity Values | LD50: 1.75 mg/kg (Oral, Mouse) (1) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Bromadiolone is a potent rodenticide. (3) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Bromadiolone is an anticoagulant and causes internal bleeding, leading to shock, loss of consciousness, and eventually death. (2) |
---|
Symptoms | Bromadiolone initially causes dehydration before progressing to bleeding complications. (2) |
---|
Treatment | The primary antidote to bromadiolone poisoning is immediate administration of vitamin K1 (initially slow intravenous injections of 10-25 mg repeated all 3-6 hours until normalisation of the prothrombin time; then 10 mg orally four times daily as a "maintenance dose"). It is an extremely effective antidote, provided the poisoning is caught before too much damage has been done to the victim's circulatory system. At high doses bromadiolone can affect the body for many months, and the antidote must be administered regularly for a long period of time. (2) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 34322 |
---|
ChEMBL ID | Not Available |
---|
ChemSpider ID | 31618 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | Not Available |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Bromadiolone |
---|
PDB ID | Not Available |
---|
ACToR ID | 13321 |
---|
Wikipedia Link | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D3102.pdf |
---|
General References | - O'Neil MJ (ed) (2001). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th ed. Whitehouse Station, NJ: Merck and Co., Inc.
- Wikipedia. Brodifacoum. Last Updated 22 June 2009. [Link]
- Wikipedia. Bromadiolone. Last Updated 1 July 2009. [Link]
- Wikipedia. Phytotoxin. Last Updated 7 August 2009. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|